research use only

AP-III-a4 (ENOblock) Glucokinase inhibitor

Cat.No.S7443

AP-III-a4 (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
AP-III-a4 (ENOblock) Glucokinase inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 631.18

Jump to

Quality Control

Batch: Purity: 99.47%
99.47

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (158.43 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 100 mg/mL

Ethanol : 100 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 631.18 Formula

C31H44ClFN8O3

Storage (From the date of receipt)
CAS No. 1177827-73-4 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles C1CCC(CC1)CNC2=NC(=NC(=N2)NCC3=CC=C(C=C3)F)NC4=CC=C(C=C4)CC(=O)NCCOCCOCCN.Cl

Mechanism of Action

Targets/IC50/Ki
enolase
(Cell-free assay)
0.576 μM
In vitro
In HCT116 cells, AP-III-a4 (ENOblock) induces cell death under hypoxia and inhibits cancer cell migration and invasion by down-regulation of AKT and Bcl-xL expression. In Huh7 hepatocytes and HEK kidney cells, it also induces glucose uptake and inhibits phosphoenolpyruvate carboxykinase (PEPCK) expression.
Kinase Assay
Enolase activity assay
Enolase activity is measured at 37°C by incubating pure enolase (3–9 U) in a buffer containing 50 mM imidazole-HCl (pH 6.8), 2.0 mM MgSO4 and 400 mM KCl in the absence or presence of AP-III-a4 (ENOblock) or NaF. A single unit of enolase is defined as the amount of enzyme that produces 1 μmol of phosphoenol pyruvate from phospho-D-glycerate/min in standard assay. The reaction is initiated by adding 1 μmol of 2-phospho-D-glycerate, and the OD is measured after 10 min of reaction time with a spectrophometer at 240 nm.
In vivo
In a HCT116-xenotransplanted zebrafish tumor xenograft model, AP-III-a4 (ENOblock) (10 μM) inhibits cancer cell migration and invasion processes. In vivo, it also causes downregulation of PEPCK expression and induction of glucose uptake, and inhibits adipogenesis and foam cell formation.
References

Applications

Methods Biomarkers Images PMID
Western blot p-AMPKα / AMPKα / p-ACC / ACC p-AKT / AKT / p-GSK3β / GSK3β / p-PRAS40 / PRAS40
S7443-WB1
30242159

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.